1. Home
  2. CIVB vs IPSC Comparison

CIVB vs IPSC Comparison

Compare CIVB & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civista Bancshares Inc.

CIVB

Civista Bancshares Inc.

HOLD

Current Price

$24.92

Market Cap

476.9M

Sector

Finance

ML Signal

HOLD

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.28

Market Cap

413.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIVB
IPSC
Founded
1884
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
476.9M
413.0M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
CIVB
IPSC
Price
$24.92
$2.28
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
$26.60
$4.25
AVG Volume (30 Days)
73.3K
899.0K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
2.90%
N/A
EPS Growth
31.34
91.30
EPS
2.64
N/A
Revenue
$19,023,000.00
$109,164,000.00
Revenue This Year
$14.88
N/A
Revenue Next Year
$5.99
N/A
P/E Ratio
$9.45
N/A
Revenue Growth
N/A
1556.76
52 Week Low
$18.95
$0.44
52 Week High
$25.83
$2.97

Technical Indicators

Market Signals
Indicator
CIVB
IPSC
Relative Strength Index (RSI) 59.31 49.62
Support Level $21.39 $2.15
Resistance Level N/A $2.67
Average True Range (ATR) 0.74 0.12
MACD -0.03 -0.00
Stochastic Oscillator 62.67 46.67

Price Performance

Historical Comparison
CIVB
IPSC

About CIVB Civista Bancshares Inc.

Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

Share on Social Networks: